, Volume 5, Issue 1, pp 107–113 | Cite as

Sacral nerve stimulation: Neuromodulation for voiding dysfunction and pain

  • Robert D. Mayer
  • Fred M. Howard
Review Article


Voiding dysfunction, which includes incontinence, retention, and chronic pelvic pain, is a relatively frequent problem that can be difficult to manage. Neuromodulation via stimulation of the sacral nerves has been shown to improve thesesymptoms, although the exact mechanisms remain elusive. Techniques for nerve stimulation may vary, depending on the disease, location of pain, and the patient’s anatomy. In addition to placement of electrodes on the sacral nerve roots, modulation has also been reported by peripheral branches of the sacral nerves including the pudendal and posterior tibial nerves. Newer surgical techniques have significantly decreased the morbidity of the procedures and increased the probability of a successful outcome.

Key Words

Neuromodulation incontinence pelvic pain 


  1. 1.
    Vignes JR, De Seze M, Dobremez E, Joseph PA, Guérin J. Sacral neuromodulation in lower urinary tract dysfunction. Adv Tech Stand Neurosurg 2005;30:177–224.CrossRefPubMedGoogle Scholar
  2. 2.
    Haque R, Winfree CJ. Spinalnerve root stimulation. Neurosurg Focus 2006;21:E4.CrossRefPubMedGoogle Scholar
  3. 3.
    Brindley GS. Emptying the bladder by stimulating sacral ventral roots. J Physiol 1974;237:15P-16P.PubMedGoogle Scholar
  4. 4.
    Fandel T, Tanagho EA. Neuromodulation in voiding dysfunction: a historical overview of neurostimulation and its application. Urol Clin North Am 2005;32:1–10.CrossRefPubMedGoogle Scholar
  5. 5.
    Siegel SW, Catanzaro F, Dijkema HE, et al. Long-term results of a multicenter study on sacral nervestimulation for treatment of urinary urge incontinence, urgency-frequency, and retention. Urology 2000;56:87–91.CrossRefPubMedGoogle Scholar
  6. 6.
    Hassouna MM, Siegel SW, Nyeholt AA, et al. Sacral neuromodulation in the treatment ofurgency-frequency symptoms: a multi-center study on efficacy and safety. J Urol 2000;163:1849–1854.CrossRefPubMedGoogle Scholar
  7. 7.
    Melzack R, Wall PD. Painmechanisms: a new theory. Science 1965;150:971–979.CrossRefPubMedGoogle Scholar
  8. 8.
    Aló KM, Holsheimer J. Newtrends in neuromodulation for the management of neuropathic pain. Neurosurgery 2002;50:690–703; discussion 703-694.CrossRefPubMedGoogle Scholar
  9. 9.
    Leng WW, Chancellor MB. Howsacral nerve stimulation neuromodulation works. Urol Clin North Am 2005;32: 11–18.CrossRefPubMedGoogle Scholar
  10. 10.
    van der Pal F, Heesakkers JP, Bemelmans BL. Current opinion on the working mechanisms of neuromodulation inthe treatment of lower urinary tract dysfunction. Curr Opin Urol 2006;16:261–267.CrossRefPubMedGoogle Scholar
  11. 11.
    de Groat WC. Integrative control of the lower urinary tract: pre-clinical perspective. Br J Pharmacol 2006; 147 Suppl 2:S25-S40.CrossRefPubMedGoogle Scholar
  12. 12.
    Morrison J, Birder L, Craggs M, et al. Neural control. In: Abrams P, Cardozo L, Khoury S, Wein A, editors. Incontinence: 3rd International Consultation on Incontinence. Plymouth, UK: Health Publications, 2005;363–422.Google Scholar
  13. 13.
    Riazimand SH, Mense S. Arat model for studying effects of sacral neuromodulation on the contractile activity of a chronically inflamed bladder. BJU Int 2004;94:158–163.CrossRefPubMedGoogle Scholar
  14. 14.
    Riazimand SH, Mense S. Interaction between neurotransmitter antagonists and effects of sacral neuromodulation in rats with chronically hyperactive bladder. BJU Int 2005;96:900–908.CrossRefPubMedGoogle Scholar
  15. 15.
    Zhou Y, Wang Y, Abdelhady M, Mourad MS, Hassouna MM. Change of vanilloid receptor 1 following neuromodulation in rats withspinal cord injury. J Surg Res 2002;107:140–144.PubMedGoogle Scholar
  16. 16.
    Wang Y, Zhou Y, Mourad MS, Hassouna MM. Neuromodulation reduces urinary frequency in rats with hydrochloric acid-induced cystitis. BJU Int 2000;86:726–730.CrossRefPubMedGoogle Scholar
  17. 17.
    Groen J, Ruud Bosch JL, van Mastrigt R. Sacral neuromodulation in women with idiopathic detrusor overactivity incontinence: decreased overactivity but unchanged bladder contraction strength and urethral resistance during voiding. J Urol 2006;175:1005–1009; discussion 1009.CrossRefPubMedGoogle Scholar
  18. 18.
    DasGupta R, Fowler CJ. Urodynamic study of women in urinary retention treated with sacral neuromodulation. J Urol 2004;171:1161–1164.CrossRefPubMedGoogle Scholar
  19. 19.
    Malaguti S, Spinelli M, Giardiello G, Lazzeri M, Van Den Hombergh U. Neurophysiological evidence may predict the outcome of sacral neuromodulation. J Urol 2003;170:2323–2326.CrossRefPubMedGoogle Scholar
  20. 20.
    Braun PM, Baezner H, Seif C, et al. Alterations of cortical electrical activity in patients with sacral neuromodulator. Eur Urol 2002;41:562–566; discussion 566–567.CrossRefPubMedGoogle Scholar
  21. 21.
    DasGupta R, Critchley HD, Dolan RJ, Fowler CJ. Changes in brainactivity following sacral neuromodulation for urinary retention. J Urol 2005;174:2268–2272.CrossRefPubMedGoogle Scholar
  22. 22.
    Blok BF, Groen J, Bosch JL, Veltman DJ, Lammertsma AA. Different brain effects during chronic and acute sacral neuromodulation in urge incontinent patients with implanted neurostimulators. BJU Int 2006;98: 1238–1243.CrossRefPubMedGoogle Scholar
  23. 23.
    Wyndaele JJ, Michielsen D, Van Dromme S. Influence of sacral neuromodulation on electrosensation of the lowerurinary tract. J Urol 2000;163:221–224.CrossRefPubMedGoogle Scholar
  24. 24.
    Chai TC, Zhang C, Warren JW, Keay S. Percutaneous sacral third nerve root neurostimulation improves symptoms and normalizes urinary HB-EGF levels and antiproliferative activity in patients withinterstitial cystitis. Urology 2000;55:643–646.CrossRefPubMedGoogle Scholar
  25. 25.
    Schmidt RA, Bruschini H, Tanagho EA. Urinary bladder and sphincter responses to stimulation of dorsal andventral sacral roots. Invest Urol 1979;16:300–304.PubMedGoogle Scholar
  26. 26.
    Schmidt RA, Senn E, Tanagho EA. Functional evaluation of sacral nerve root integrity: report of atechnique. Urology 1990;35:388–392.CrossRefPubMedGoogle Scholar
  27. 27.
    Hohenfellner M, Schultz-Lampel D, Dahms S, Matzel K, Thuroff JW. Bilateral chronic sacral neuromodulation for treatment of lower urinary tract dysfunction. J Urol 1998;160:821–824.CrossRefPubMedGoogle Scholar
  28. 28.
    Scheepens WA, Weil EH, van Koeveringe GA, et al. Buttock placement of the implantable pulsegenerator: a new implantation technique for sacral neuromodulation—a multicenter study. Eur Urol 2001;40:434–438.CrossRefPubMedGoogle Scholar
  29. 29.
    Chai TC, Mamo GJ. Modified techniques of S3 foramen localization and lead implantation in S3 neuromodulation. Urology 2001;58:786–790.CrossRefPubMedGoogle Scholar
  30. 30.
    Spinelli M, Giardiello G, Arduini A, van den Hombergh U. New-percutaneous technique of sacral nerve stimulation has high initial success rate: preliminary results. Eur Urol 2003;43:70–74.CrossRefPubMedGoogle Scholar
  31. 31.
    Spinelli M, Giardiello G, Gerber M, Arduini A, van den Hombergh U, Malaguti S. New sacral neuromodulation lead for percutaneous implantation using local anesthesia: description and first experience. J Urol 2003;170:1905–1907.CrossRefPubMedGoogle Scholar
  32. 32.
    Peters KM, Carey JM, Konstandt DB. Sacral neuromodulation for the treatment of refractory interstitial cystitis: outcomes based on technique. Int Urogynecol J 2003;14:223–228; discussion 228.CrossRefGoogle Scholar
  33. 33.
    Kessler TM, Madersbacher H, Kiss G. Prolonged sacral neuromodulation testing using permanent leads: a more reliable patient selection method? Eur Urol 2005;47:660–665.CrossRefPubMedGoogle Scholar
  34. 34.
    Spinelli M, Weil E, Ostardo E, et al. New tined lead electrode in sacral neuromodulation: experience from a multicentre European study. World J Urol 2005;23:225–229.CrossRefPubMedGoogle Scholar
  35. 35.
    Cohen BL, Tunuguntla HS, Gousse A. Predictors of success for first stage neuromodulation: motor versus sensory response. J Urol 2006;175:2178–2180; discussion 2180-2171.CrossRefPubMedGoogle Scholar
  36. 36.
    Amundsen CL, Romero AA, Jamison MG, Webster GD. Sacral neuromodulation for intractable urge incontinence: are there factors associated with cure? Urology 2005;66:746–750.CrossRefPubMedGoogle Scholar
  37. 37.
    Feler CA, Whitworth LA, Fernandez J. Sacral neuromodulation for chronic pain conditions. Anesthesiol Clin North Am 2003;21:785–795.CrossRefGoogle Scholar
  38. 38.
    Brindley GS. The sacral anterior root stimulator as a means of managing the bladder in patients with spinal cord lesions. Baillieres Clin Neurol 1995;4:1–13.PubMedGoogle Scholar
  39. 39.
    Spinelli M, Bertapelle P, Cappellano F, et al. Chronic sacral neuromodulation in patients with lower urinary tract symptoms: results from a national register. J Urol 2001;166:541–545.CrossRefPubMedGoogle Scholar
  40. 40.
    Swinn MJ, Wiseman OJ, Lowe E, Fowler CJ. The cause and natural history of isolated urinary retention in young women [Erratum in: J Urol 2002;167:1805]. J Urol 2002;167:151–156.CrossRefPubMedGoogle Scholar
  41. 41.
    Swinn MJ, Kitchen ND, Goodwin RJ, Fowler CJ. Sacral neuromodulation for women with Fowler’s syndrome. Eur Urol 2000;38:439–443.CrossRefPubMedGoogle Scholar
  42. 42.
    Grünewald V, Jonas U. Neurostimulation for lower urinary tract voiding problems. Curr Urol Rep 2000;1:199–203.CrossRefGoogle Scholar
  43. 43.
    Shaker HS, Hassouna M. Sacral root neuromodulation in idiopathic nonobstructive chronic urinary retention. J Urol 1998;159:1476–1478.CrossRefPubMedGoogle Scholar
  44. 44.
    Latini JM, Alipour M, Kreder KJ Jr. Efficacy of sacral neuromodulation for symptomatic treatment of refractory urinary urge incontinence. Urology 2006;67:550–553; discussion 553–554.CrossRefPubMedGoogle Scholar
  45. 45.
    Sutherland SE, Lavers A, Carlson A, Holtz C, Kesha J, Siegel SW. Sacral nerve stimulation for voiding dysfunction: one institution’s 11-year experience. Neurourol Urodyn 2007;26:19–28; discussion 36.CrossRefPubMedGoogle Scholar
  46. 46.
    DasGupta R, Wiseman OJ, Kitchen N, Fowler CJ. Long-term results of sacral neuromodulation for women with urinary retention. BJU Int 2004;94:335–337.CrossRefPubMedGoogle Scholar
  47. 47.
    Elkelini M, Hassouna MM. Canadian experience in sacral neuromodulation. Urol Clin North Am 2005;32: 41–49.CrossRefPubMedGoogle Scholar
  48. 48.
    Hohenfellner M, Humke J, Hampel C, et al. Chronic sacral neuromodulation for treatment of neurogenic bladder dysfunction: long-term results with unilateral implants. Urology 2001;58:887–892.CrossRefPubMedGoogle Scholar
  49. 49.
    Brindley GS, Rushton DN. Long-term follow-up of patients with sacral anterior root stimulator implants. Paraplegia 1990;28:469–475.PubMedGoogle Scholar
  50. 50.
    Brindley GS. The Ferrier lecture, 1986. The actions of parasympathetic and sympathetic nerves in human micturition, erection and seminal emission, and their restoration in paraplegic patients by implanted electrical stimulators. Proc R Soc Lond B Biol Sci 1988;235: 111–120.CrossRefPubMedGoogle Scholar
  51. 51.
    Hohenfellner M, Dahms SE, Matzel K, Thuroff JW. Sacral neuromodulation for treatment of lower urinary tract dysfunction. BJU Int 2000;85(Suppl 3):10–19; discussion 22–23.PubMedGoogle Scholar
  52. 52.
    Whitmore KE, Payne CK, Diokno AC, Lukban JC. Sacral neuromodulation in patients with interstitial cystitis: a multicenter clinical trial. Int Urogynecol J 2003;14:305–308; discussion 308–309.CrossRefGoogle Scholar
  53. 53.
    Maher CF, Carey MP, Dwyer PL, Schlüter PL. Percutaneous sacral nerve root neuromodulation for intractable interstitial cystitis. J Urol 2001;884–886.Google Scholar
  54. 54.
    Siegel S, Paszkiewicz E, Kirkpatrick C, Hinkel B, Oleson K. Sacral nerve stimulation in patients with chronic intractable pelvic pain. J Urol 2001;166:1742–1745.CrossRefPubMedGoogle Scholar
  55. 55.
    Everaert K, Devulder J, De Muynck M, et al. The pain cycle: implications for the diagnosis and treatment of pelvic pain syndromes. Int Urogynecol J 2001;12:9–14.CrossRefGoogle Scholar
  56. 56.
    Peters KM, Konstandt D. Sacral neuromodulation decreases narcotic requirements in refractory interstitial cystitis. BJU Int 2004;93:777–779.CrossRefPubMedGoogle Scholar
  57. 57.
    Comiter CV. Sacral neuromodulation for the symptomatic treatment of refractory interstitial cystitis: a prospective study. J Urol 2003;169:1369–1373.CrossRefPubMedGoogle Scholar
  58. 58.
    Govier FE, Litwiller S, Nitti V, Kreder KJ Jr, Rosenblatt P. Percutaneous afferent neuromodulation for the refractory overactive bladder: results of a multicenter study. J Urol 2001;165:1193–1198.CrossRefPubMedGoogle Scholar
  59. 59.
    van Balken MR, Vergunst H, Bemelmans BL. Prognostic factors for successful percutaneous tibial nerve stimulation. Eur Urol 2006;49:360–365.CrossRefPubMedGoogle Scholar
  60. 60.
    Congregado Ruiz B, Pena Outeiriño XM, Campoy Martínez P, León Dueñas E, Leal López A. Peripheral afferent nerve stimulation for treatment of lower urinary tract irritative symptoms. Eur Urol 2004;45:65–69.CrossRefPubMedGoogle Scholar
  61. 61.
    Groen J, Amiel C, Bosch JL. Chronic pudendal nerve neuromodulation in women with idiopathic refractory detrusor overactivity incontinence: results of a pilot study with a novel minimally invasive implantable mini-stimulator. Neurourol Urodyn 2005;24:226–230.CrossRefPubMedGoogle Scholar
  62. 62.
    Peters KM, Feber KM, Bennett RC. Sacral versus pudendal nerve stimulation for voiding dysfunction: a prospective, single-blinded, randomized, crossover trial. Neurourol Urodyn 2005;24:643–647.CrossRefPubMedGoogle Scholar
  63. 63.
    Spinelli M, Malaguti S, Giardiello G, Lazzeri M, Tarantola J, Van Den Hombergh U. A new minimally invasive procedure for pudendal nerve stimulation to treat neurogenic bladder: description of the method and preliminary data. Neurourol Urodyn 2005;24:305–309.CrossRefPubMedGoogle Scholar

Copyright information

© Springer New York 2008

Authors and Affiliations

  1. 1.Department of UrologyUniversity of Rochester Medical CenterRochester
  2. 2.Department of Obstetrics and GynecologyUniversity of RochesterRochester

Personalised recommendations